LeutinimAZ
LeutinimAZ
Medical Literature on LeutinimAZ
Introduction
LeutinimAZ is a dietary supplement formulated with key antioxidants and carotenoids, including Lycopene, Lutein, Vitamin A, Astaxanthin, and Zeaxanthin. These components are well-known for their potential benefits in supporting eye health, reducing oxidative stress, and promoting overall well-being.
Composition and Active Ingredients
Lycopene
Source: Lycopene is a carotenoid found primarily in tomatoes and other red fruits and vegetables.
Benefits: Lycopene is known for its potent antioxidant properties, which help protect cells from oxidative damage. Studies suggest it may reduce the risk of certain cancers, cardiovascular diseases, and age-related macular degeneration (AMD) .
Lutein
Source: Lutein is a carotenoid present in green leafy vegetables like spinach and kale.
Benefits: Lutein accumulates in the retina and is known to filter harmful blue light, thus protecting eye health. It is associated with a reduced risk of AMD and cataracts .
Vitamin A
Source: Vitamin A can be found in liver, dairy products, and beta-carotene-rich vegetables such as carrots and sweet potatoes.
Benefits: Essential for maintaining good vision, immune function, and skin health. Vitamin A deficiency can lead to night blindness and increase the risk of eye infections .
Astaxanthin
Source: Astaxanthin is a powerful antioxidant found in microalgae, salmon, trout, and krill.
Benefits: Known for its anti-inflammatory and antioxidant effects, astaxanthin supports skin health, enhances immune response, and may improve athletic performance and cardiovascular health .
Zeaxanthin
Source: Zeaxanthin is present in high amounts in corn, eggs, and leafy greens.
Benefits: Similar to lutein, zeaxanthin is concentrated in the macula of the eye and protects against blue light-induced oxidative damage. It plays a crucial role in maintaining eye health and reducing the risk of AMD .
Mechanism of Action
The combination of these antioxidants in LeutinimAZ works synergistically to combat oxidative stress, a key factor in aging and various diseases. By neutralizing free radicals, these compounds help preserve cellular integrity and function, particularly in the eyes and skin.
Oxidative Stress Reduction: The antioxidants in LeutinimAZ scavenge free radicals, reducing oxidative stress and protecting cells from damage.
Anti-inflammatory Properties: Many of the ingredients, such as astaxanthin, have anti-inflammatory effects that contribute to overall health.
Eye Health Support: Lutein and zeaxanthin specifically accumulate in the retina, where they filter harmful blue light and reduce the risk of AMD.
Immune Function Enhancement: Vitamin A is crucial for maintaining a robust immune system.
Clinical Evidence and Research
Lycopene: Research has shown that lycopene supplementation can significantly reduce markers of oxidative stress and inflammation, potentially lowering the risk of chronic diseases like heart disease and cancer .
Lutein and Zeaxanthin: Numerous studies indicate that these carotenoids are effective in reducing the progression of AMD and improving visual performance, particularly in low-light conditions .
Vitamin A: Clinical trials have demonstrated that adequate vitamin A intake is essential for maintaining good vision and immune function, with deficiency linked to increased susceptibility to infections and eye disorders .
Astaxanthin: Studies suggest that astaxanthin supplementation can improve skin elasticity, reduce wrinkles, and enhance physical endurance, highlighting its broad health benefits .
Conclusion
LeutinimAZ, with its blend of potent antioxidants and carotenoids, offers comprehensive support for eye health, reduces oxidative stress, and promotes overall well-being. The synergistic effects of its ingredients are backed by extensive scientific research, making it a valuable supplement for maintaining health and preventing disease.
References
Giovannucci, E. (1999). Tomatoes, tomato-based products, lycopene, and cancer: review of the epidemiologic literature. Journal of the National Cancer Institute, 91(4), 317-331.
Rissanen, T. H., et al. (2002). Lycopene, atherosclerosis, and coronary heart disease. Experimental Biology and Medicine, 227(10), 900-907.
Seddon, J. M., et al. (1994). Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. JAMA, 272(18), 1413-1420.
Mozaffarieh, M., et al. (2003). Lutein supplementation improves visual acuity and symptoms of visual fatigue in patients with asthenopia. International Journal of Ophthalmology, 226(2), 129-133.
Sommer, A. (2008). Vitamin A deficiency and clinical disease: an historical overview. Journal of Nutrition, 138(10), 1835-1839.
West, K. P. Jr. (2003). Vitamin A deficiency disorders in children and women. Food and Nutrition Bulletin, 24(4_suppl1), S78-S90.
Higuera-Ciapara, I., et al. (2006). Astaxanthin: a review of its chemistry and applications. Critical Reviews in Food Science and Nutrition, 46(2), 185-196.
Fassett, R. G., & Coombes, J. S. (2011). Astaxanthin: a potential therapeutic agent in cardiovascular disease. Marine Drugs, 9(3), 447-465.
Ma, L., et al. (2006). Effects of lutein and zeaxanthin on macular pigment and visual performance. Nutrition Reviews, 64(9), 464-470.
Bernstein, P. S., et al. (2002). Zeaxanthin and lutein in human macula and retina. Investigative Ophthalmology & Visual Science, 43(4), 1168-1173.
Arab, L., Steck-Scott, S., & Bowen, P. (2001). Lycopene and the lung. Experimental Biology and Medicine, 226(10), 1037-1045.
Krinsky, N. I., & Johnson, E. J. (2005). Carotenoid actions and their relation to health and disease. Molecular Aspects of Medicine, 26(6), 459-516.
Age-Related Eye Disease Study 2 Research Group. (2013). Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration. JAMA, 309(19), 2005-2015.
West, K. P. Jr. (2002). Extent of vitamin A deficiency among preschool children and women of reproductive age. Journal of Nutrition, 132(9), 2857S-2866S.
Tominaga, K., et al. (2012). Cosmetic benefits of astaxanthin on humans subjects. Acta Biochimica Polonica, 59(1), 43-47.
Iwamoto, T., et al. (2000). Effect of astaxanthin on exercise-induced muscle damage. Biological & Pharmaceutical Bulletin, 23(6), 810-813.
"Diabetes can be particularly dangerous for the eyes due to its potential to cause several serious conditions, collectively known as diabetic eye disease. These conditions include:
Diabetic Retinopathy: High blood sugar levels can damage the blood vessels in the retina, the light-sensitive tissue at the back of the eye. This can lead to leaking blood vessels, swelling, and abnormal blood vessel growth. If untreated, it can cause severe vision loss or blindness.
Diabetic Macular Edema (DME): This is a complication of diabetic retinopathy where fluid accumulates in the macula, the part of the retina responsible for sharp, central vision. Swelling in the macula can lead to blurred vision and vision loss.
Cataracts: People with diabetes are at a higher risk of developing cataracts at a younger age. Cataracts cause the lens of the eye to become cloudy, leading to impaired vision.
Glaucoma: Diabetes increases the risk of glaucoma, a group of diseases that damage the optic nerve, often due to high pressure in the eye. This can lead to gradual vision loss and, if untreated, blindness.
Retinal Detachment: Severe diabetic retinopathy can cause scar tissue to form on the retina, which may pull it away from the back of the eye. This is a medical emergency that can result in permanent vision loss if not treated promptly.
Maintaining good blood sugar control, regular eye examinations, and early detection and treatment of eye problems are crucial for people with diabetes to protect their vision.
Our Products
